ERBB2 and breast cancer: In Rarb−/− mice (RARβ-null mice), ErbB2-induced mammary tumors display a decrease in the proliferation of neoplastic cells, as well as a diminution of the angiogenetic process, the levels of collagen and the recruitment of inflammatory cells.